This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
ActionAid International: Globalizing Governance, Localizing Accountability
Ebrahim, Alnoor; Gordon, RachelCase HBS-311004-EAs a global NGO working in 45 countries, ActionAid International aims to eradicate poverty by addressing its underlying causes such as injustice and inequality. This case follows a series of radical transformations implemented by the organization's CEO, Ramesh Singh--a power shift from its headquarters in London to an international secretariat in Johannesburg; a new federated governance structure that increases the influence of units in Africa an...Starting at €8.20
-
American Express: decidir sobre un modelo de trabajo híbrido tras la crisis de COVID-19 (B)
Almandoz, John; Reiche, Sebastian; Tatge, LarisaCase DPO-815Corporate Governance, Leadership and People ManagementStarting at €5.74
-
Boosting Engagement & Commitment
García Pont, Carlos; Canales, J. Ignacio; Rothbard, Nancy; Milliken, Frances J.; Tatge, LarisaDossier DOS-29-EInformation Technologies, Knowledge and Communication, Leadership and People ManagementTo the office and beyond! Find inspiration to reach new heights -- personally and professionally -- in this dossier.Starting at €15.00
-
Deworming Kenya: Translating Research into Action (A) and (B), Teaching Note
Ashraf, Nava; Shah, Neil Buddy; Gordon, RachelTeaching Note HBS-910002-ETeaching Note for 910001.Starting at €0.00
-
Whose Money Is It Anyway (B)
Narayanan, V.G.; Hamermesh, Richard G.; Gordon, RachelCase HBS-810013-EAccounting and ControlThe case describes the various reactions of doctors and administrators to the solutions they developed.Starting at €5.74
-
Deworming Kenya: Translating Research into Action (B)
Ashraf, Nava; Shah, Neil Buddy; Gordon, RachelCase HBS-910027-EKaren Levy and her colleague, Margaret Ndanyi, learn the results of their nation-wide effort to rid Kenyan school children of parasitic worm infection.Starting at €5.74
-
Playing with Fire at Sittercity (A), Teaching Note
Wasserman, Noam; Gordon, RachelTeaching Note HBS-810120-EEntrepreneurshipNote: This mini-Teaching Note was created to provide a brief overview of the teaching plan for this case. Please see the upcoming, fuller Teaching Note for an extensive overview of the underlying research, pedagogical approaches, and other teaching issues.Starting at €0.00
-
Generation Health: A Pioneer in Genetics Benefit Management (A)
Higgins, Robert F.; Marrazzo, Jeffrey D.; Gordon, RachelCase HBS-810007-EEntrepreneurshipGeneration Health, a pioneer in the new field of genetics benefit management, and newly formed company faces many strategic issues. CEO Per Lofberg is in the midst of negotiating a partnership with a major pharmacy benefit management company. As part of these negotiations, Lofberg must decide whether the time is right for such a strategic partner when Generation Health has only been founded for a year. At the same time, Lofberg must recruit for t...Starting at €8.20
-
Dartmouth-Hitchcock Medical Center: Spine Care
Huckman, Robert S.; Porter, Michael E.; Gordon, Rachel; Kindred, NatalieCase HBS-609016-EStrategyDescribes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in physical medicine and pain management, mental health providers, and occupational and physical therapists. The Center was created to address what its founder, James Weinstein, M.D., s...Starting at €8.20
-
Adnexus Therapeutics, Inc.: Considering the Exit
Sato, Vicki L.; Gordon, RachelCase HBS-609015-EService and Operations ManagementDr. John Mendlein, CEO of Adnexus Therapeutics Inc., (Adnexus), a private biotechnology company, must decide whether to pursue acquisition talks with Bristol-Myers Squibb (BMS) after a successful six month collaboration or continue with Adnexus' planned IPO.Starting at €8.20